Form 8-K - Current report:
SEC Accession No. 0001213900-25-061531
Filing Date
2025-07-03
Accepted
2025-07-03 16:45:29
Documents
12
Period of Report
2025-06-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0247862-8k_silo.htm   iXBRL 8-K 35777
  Complete submission text file 0001213900-25-061531.txt   200043

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE silo-20250627.xsd EX-101.SCH 3020
3 XBRL LABEL FILE silo-20250627_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE silo-20250627_pre.xml EX-101.PRE 22362
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0247862-8k_silo_htm.xml XML 3616
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 251106101
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)